Morocco orders COVID-19 vaccine as cases approach 100,000
Morocco on Friday signed a deal with Russia's R-Pharm to buy a COVID-19 vaccine produced under a licence from Britain’s AstraZeneca, the health ministry said, as its total number of cases approached 100,000. The Ministry did not provide details on the cost and quantity of the order. AstraZeneca licensed R-Pharm in July to produce the vaccine it developed together with Oxford University.
- Country:
- Morocco
Morocco on Friday signed a deal with Russia's R-Pharm to buy a COVID-19 vaccine produced under a licence from Britain's AstraZeneca, the health ministry said, as its total number of cases approached 100,000. The Ministry did not provide details on the cost and quantity of the order.
AstraZeneca licensed R-Pharm in July to produce the vaccine it developed together with Oxford University. This month, Morocco started taking part in clinical trials of China's Sinopharm vaccine.
The North African country added a daily record 2,760 cases to its confirmed total on Friday, meaning it has recorded 97,264 in all, including 1,755 deaths. AstraZeneca has said it is close to having capacity to produce 3 billion doses at sites set up around the world, also sourcing from third-party manufacturers, to supply various governments and organisations. It has a larger order book than any other vaccine developer.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- AstraZeneca
- Morocco
- Russia
- China
- Britain
- Ministry
- Oxford University
- North African
- Sinopharm
- COVID-19
ALSO READ
China commerce ministry says Envalior to inherit 8.2% anti-dumping tax
Athletics-Ujah recalled to Britain's relay squad after serving doping ban
EU, Britain and Spain to hold more talks on post-Brexit status of Gibraltar
EU, Britain and Spain say significant progress made in talks on post-Brexit status of Gibraltar
Indian foreign ministry advises against travel to Iran, Israel